Literature DB >> 23810832

Morphological features of iPS cells generated from Fabry disease skin fibroblasts using Sendai virus vector (SeVdp).

Shiho Kawagoe1, Takashi Higuchi, Manami Otaka, Yohta Shimada, Hiroshi Kobayashi, Hiroyuki Ida, Toya Ohashi, Hirotaka J Okano, Mahito Nakanishi, Yoshikatsu Eto.   

Abstract

We generated iPS cells from human dermal fibroblasts (HDFs) of Fabry disease using a Sendai virus (SeVdp) vector; this method has been established by Nakanishi et al. for pathogenic evaluation. We received SeVdp vector from Nakanishi and loaded it simultaneously with four reprogramming factors (Klf4, Oct4, Sox2, and c-Myc) to HDFs of Fabry disease; subsequently, we observed the presence of human iPS-like cells. The Sendai virus nucleocapsid protein was not detected in the fibroblasts by RT-PCR analysis. Additionally, we confirmed an undifferentiated state, alkaline phosphatase staining, and the presence of SSEA-4, TRA-1-60, and TRA-1-81. Moreover, ultrastructural features of these iPS cells included massive membranous cytoplasmic bodies typical of HDFs of Fabry disease. Thus, we successfully generated human iPS cells from HDFs of Fabry disease that retained the genetic conditions of Fabry disease; also, these abnormal iPS cells could not be easily differentiated into mature cell types such as neuronal cells, cardiomyocytes, etc. because of a massive accumulation of membranous cytoplasmic bodies in lysosomes, possibly the persistent damages of intracellular architecture.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fabry disease; Sendai virus vector; Ultrastructure; iPS cells

Mesh:

Year:  2013        PMID: 23810832     DOI: 10.1016/j.ymgme.2013.06.003

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  27 in total

1.  Advanced feeder-free generation of induced pluripotent stem cells directly from blood cells.

Authors:  Ras Trokovic; Jere Weltner; Ken Nishimura; Manami Ohtaka; Mahito Nakanishi; Veikko Salomaa; Anu Jalanko; Timo Otonkoski; Aija Kyttälä
Journal:  Stem Cells Transl Med       Date:  2014-10-29       Impact factor: 6.940

Review 2.  Human-Induced Pluripotent Stem Cell-Based Modeling of Cardiac Storage Disorders.

Authors:  Bradley C Nelson; Sherin I Hashem; Eric D Adler
Journal:  Curr Cardiol Rep       Date:  2017-03       Impact factor: 2.931

Review 3.  Advances in RNA Viral Vector Technology to Reprogram Somatic Cells: The Paramyxovirus Wave.

Authors:  Brenna Sharp; Ramya Rallabandi; Patricia Devaux
Journal:  Mol Diagn Ther       Date:  2022-06-28       Impact factor: 4.476

Review 4.  Glycosylation and stem cells: Regulatory roles and application of iPSCs in the study of glycosylation-related disorders.

Authors:  Ryan P Berger; Michelle Dookwah; Richard Steet; Stephen Dalton
Journal:  Bioessays       Date:  2016-09-26       Impact factor: 4.345

Review 5.  Disease models for the development of therapies for lysosomal storage diseases.

Authors:  Miao Xu; Omid Motabar; Marc Ferrer; Juan J Marugan; Wei Zheng; Elizabeth A Ottinger
Journal:  Ann N Y Acad Sci       Date:  2016-05-04       Impact factor: 5.691

Review 6.  Human-induced pluripotent stem cell approaches to model inborn and acquired metabolic heart diseases.

Authors:  Anita M Chanana; June-Wha Rhee; Joseph C Wu
Journal:  Curr Opin Cardiol       Date:  2016-05       Impact factor: 2.161

7.  Stem Cell Applications in Lysosomal Storage Disorders: Progress and Ongoing Challenges.

Authors:  Sevil Köse; Fatima Aerts-Kaya; Duygu Uçkan Çetinkaya; Petek Korkusuz
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 8.  Choices for Induction of Pluripotency: Recent Developments in Human Induced Pluripotent Stem Cell Reprogramming Strategies.

Authors:  Marinka Brouwer; Huiqing Zhou; Nael Nadif Kasri
Journal:  Stem Cell Rev Rep       Date:  2016-02       Impact factor: 5.739

Review 9.  Human-induced pluripotent stem cells as models for rare cardiovascular diseases: from evidence-based medicine to precision medicine.

Authors:  Ziwei Pan; Antje Ebert; Ping Liang
Journal:  Pflugers Arch       Date:  2020-11-18       Impact factor: 3.657

Review 10.  hiPSC-derived iMSCs: NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicine.

Authors:  Vikram Sabapathy; Sanjay Kumar
Journal:  J Cell Mol Med       Date:  2016-04-21       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.